Assessment of sensory perception alterations for patients receiving Antineoplastic chemotherapy | ||
| Port Said Scientific Journal of Nursing | ||
| Article 3, Volume 7, Issue 1, June 2020, Pages 94-118 PDF (613.67 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/pssjn.2020.29623.1024 | ||
| Authors | ||
| walaa alsafy ahmed* 1; Mona Abed El-rahman Mohamed2; Amany Gamal Elgharieb3 | ||
| 1medical surgical,faculty of nursing,port said university,port said city | ||
| 2Medical surgical nursing department , faculty of nursing , portsaid university | ||
| 3Medical surgical department , faculty of nursing , portsaid university | ||
| Abstract | ||
| Background: Alteration in sensory perception that occurs during anti neoplastic chemotherapy can seriously affect the health and nutritional status of patients, everyday life activities and recovery possibilities. Aim: This study aimed to assessment of sensory perception alteration for patients receiving anti neoplastic chemotherapy. Subjects and method: Across section study design using a mixed-methods study combining qualitative and quantitative approaches of data collection was adapted. A convenient sample from patients receiving anti neoplastic chemotherapy that were available within 6 months. The present study included a group of 100 Cancer patients receiving ACH. Data were collected through Sensory administrated questionnaire for quantitative data and interview schedule for qualitative data collection. Results: The majority of the patients in the study displayed alteration of taste perception reported the highest mean value (66.35) followed by sense of tactile perception alteration (57.54) then visual perception alteration(45.41) followed by hearing perception alteration (39.81) then sense of position perception alteration(37.97) and finally was sense of smell perception alteration (34.61) ,there are statistically significant relation between sense of vision and sense of tactile perception alteration with the starting date of ACH at p value ˂ 0.05. Also, six themes were identified in the current study which reported that more than half of patients express taste perception alterations. Recommendations: conducting educational programs to improve patient's knowledge and a wariness regarding receiving of ACH. Conclusion: Sensory perception alterations during ACH are significant complaints of cancer patients. In addition to reducing life satisfaction, poor compliance and even decreased response to therapy. | ||
| Keywords | ||
| Antineoplastic Chemotherapy; nursing management; mixed methods; sensory perception alteration | ||
| References | ||
|
Amézaga, J., Alfaro, B., Ríos, Y., Larraioz, A., Ugartemendia, G., Urruticoechea, A., & Tueros, I. (2018). Assessing taste and smell alterations in cancer patients undergoing chemotherapy according to treatment. Supportive Care in Cancer, 26(12), 4077-4086
Bernhardson, B.-M., Tishelman, C., & Rutqvist, L. E. (2007). Chemosensory changes experienced by patients undergoing cancer chemotherapy: a qualitative interview study. Journal of Pain and Symptom Management, 34(4), 403-412.
Belqaid, K., Tishelman, C., Orrevall, Y., Månsson-Brahme, E., &Bernhardson, B.-M. (2018). Dealing with taste and smell alterations—A qualitative interview study of people treated for lung cancer. PloS one, 13(1), e0191117
Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative research in psychology, 3(2), 77-101.
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 68(6), 394-424. doi:10.3322/caac.21492.
Brisbois, T. D., de Kock, I. H., Watanabe, S. M., Baracos, V. E., &Wismer, W. V. (2011). Characterization of chemosensory alterations in advanced cancer reveals specific chemosensory phenotypes impacting dietary intake and quality of life. Journal of Pain and Symptom Management, 41(4), 673-683.
Bozzetti, F., Mariani, L., Lo Vullo, S., Amerio, M. L., Biffi, R., Caccialanza, G., .Vigevani, E. (2012). Thenutritional risk in oncology: a study of 1,453 cancer outpatients. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 20(8), 1919-1928. doi:10.1007/s00520-012-1387-x
De Vries, Y. C., Winkels, R. M., van den Berg, M. M. G. A., de Graaf, C., Kelfkens, C. S., de Kruif, J. T. C. M., . . . Boesveldt, S. (2018). Altered food preferences and chemosensory perception during chemotherapy in breast cancer patients: A longitudinal comparison with healthy controls. Food Quality and Preference, 63, 135-143. doi:https://doi.org/10.1016/j.foodqual.2017.09.003
Drareni, K., Dougkas, A., Giboreau, A., Laville, M., Souquet, P.-J., &Bensafi, M. (2019). Relationship between food behavior and taste and smell alterations in cancer patients undergoing chemotherapy: A structured review. Paper presented at the Seminars in oncology.
Espy, D. D., Yang, F., Bhatt, T., & Pai, Y.-C. (2010). Independent influence of gait speed and step length on stability and fall risk. Gait & posture, 32(3), 378-382.
Halyard, M. Y. (2009). Taste and smell alterations in cancer patients--real problems with few solutions. J Support Oncol, 7(2), 68-69.
Harman, L. E. (2016). Ophthalmic complications related to chemotherapy in medically complex patients. Cancer Control, 23(2), 150-156.
Haugnes, H. S., Stenklev, N. C., Brydøy, M., Dahl, O., Wilsgaard, T., Laukli, E., &Fosså, S. D. (2018). Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study. Acta Oncologica, 57(8), 1075-1083. doi:10.1080/0284186X.2018.1433323
Marnitz, S., Schermeyer, L., Dommerich, S., Köhler, C., Olze, H., Budach, V., &Martus, P. (2018). Age-corrected hearing loss after chemoradiation in cervical cancer patients. Strahlentherapie und Onkologie, 194(11), 1039-1048. doi:10.1007/s00066-018-1347-6
Monfort, S. M., Pan, X., Patrick, R., Ramaswamy, B., Wesolowski, R., Naughton, M. J., . . . Lustberg, M. B. (2017). Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients. Breast cancer research and treatment, 164(1), 69-77.
Moll, A. C., de Boer, M. R., Bouter, L. M., & Singh, N. (2019). Principles of Cancer Epidemiology. In A. D. Singh & B. E. Damato (Eds.), Clinical Ophthalmic Oncology: Basic Principles (pp. 1-10). Cham: Springer International Publishing.
Noszek, L., Budai, B., Prekopp, P., Széchenyi, R., Szőnyi, M., Talpai, S., . . . Geczi, L. (2017). Early ototoxic changes in patients withgerm cell tumor after first cycle of cisplatin‐based therapy. The Laryngoscope, 127(8), E277-E282.
Omoti, A., &Omoti, C. (2006). Ocular toxicity of sys(Miller et al., 2016)temic anticancer chemotherapy. Pharmacy practice, 4, 55-59.
Rhodes, V. A., McDaniel, R. W., Hanson, B., Markway, E., & Johnson, M. (1994). Sensory perception of patients on selected antineoplastic chemotherapy protocols. Cancer Nursing, 17(1), 45-51.
Seretny, M., Currie, G. L., Sena, E. S., Ramnarine, S., Grant, R., MacLeod, M. R., . . . Fallon, M. (2014). Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain, 155(12), 2461-2470. doi:10.1016/j.pain.2014.09.020
Siegel, R. L., Miller, K. D., & Jemal, A. (2019). Cancer statistics, 2019. CA: A Cancer Journal for Clinicians, 69(1), 7-34.
Stout, N. L., & Sabo Wagner, S. (2019). Antineoplastic Therapy Side Effects and Polypharmacy in Older Adults With Cancer. Topics in Geriatric Rehabilitation, 35(1), 15-30. doi:10.1097/tgr.
Thiermann, F., & Buchbauer, G. (2017). Influence of drugs on smelling capacity. A review. Flavour and Fragrance Journal, 32(3), 147-158.
van Oort, S., Kramer, E., de Groot, J.-W., & Visser, O. (2018). Taste alterations and cancer treatment. Current opinion in supportive and palliative care, 12(2), 162-167.
Zabernigg, A., Gamper, E. M., Giesinger, J. M., Rumpold, G., Kemmler, G., Gattringer, K., ... & Holzner, B. (2010). Taste alterations in cancer patients receiving chemotherapy: a neglected side effect?. The oncologist, 15(8), 913. | ||
|
Statistics Article View: 403 PDF Download: 1,171 |
||
